Cite
HARVARD Citation
Fukui, S. et al. (2022). A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet's disease. Scandinavian journal of rheumatology. pp. 81-82. [Online].